Mallinckrodt/NIH OxiFirst Fetal Oximetry Trial Will Evaluate Cesarean Rates

Results of an NIH-supported, postmarket study of Mallinckrodt's OxiFirst fetal oxygen saturation monitoring system, evaluating the associated cesarean section rate, are at least four years away, according to the National Institutes of Health.